Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
430.00    -5.00 (-1.15%)
Bid:
428.00
Ask:
430.00
Spread: 2.00 (0.467%)
Market Cap: £211.48m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Director/PDMR Shareholding

22 Dec 2017 12:27

RNS Number : 2540A
Zotefoams PLC
22 December 2017
 

Zotefoams plc (the 'Company')

 

Directors' Shareholdings

 

On 20 December 2017, David Stirling, Group CEO, exercised his option under the Company's Approved Share Option Plan over 28,116 Ordinary Shares of 5p ('Shares') each in the capital of the Company at an exercise price of £1.067 per share. Mr Stirling sold all the Shares on 20 December 2017 at a price of £4.55 per share.

 

The Company was notified on 20 December 2017 that Mr Douglas Robertson, a Non-Executive Director of the Company, bought 5,416 Ordinary shares of 5p each in the Company on 20 December 2017 at a price of £4.59 per share.

 

Following this purchase, Mr Robertson is interested in 5,416 Ordinary Shares, representing just over 0.01% of the Company's issued share capital. Mr Stirling's shareholding remains unchanged.

 

The Notification of Dealing Forms can be found below.

 

This notification is made in accordance with the Market Abuse Regulation.

 

Enquiries:

James Kindell

Company Secretary

Zotefoams plc

 

22 December 2017

 

020 8664 1600

 

About Zotefoams plc:

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE® polyolefin and ZOTEK® high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®).

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

 

 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Stirling

2.

Reason for the notification

a)

Position/status: Group CEO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise of an option under the Approved Share Option Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£1.067

28,116

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£1.067

28,116

£29,999.77

e)

Date of the transaction: 2017-12-20

f)

Place of the transaction: Outside a trading venue

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Sale of shares from exercising an option under the Approved Share Option Plan.

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£4.55

28,116

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£4.55

28,116

£127,927.80

e)

Date of the transaction: 2017-12-20, 15:19:00

f)

Place of the transaction: XLON / BATE / CHIX / TRQX

 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Douglas Robertson

2.

Reason for the notification

a)

Position/status: Non-Executive Director

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Purchase of shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£4.59

5,416

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£4.59

5,416

£24,859.44

e)

Date of the transaction: 2017-12-20; 12.33.07

f)

Place of the transaction: XLON / BATE / CHIX / TRQX

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAAAAAAKXFFF
Date   Source Headline
16th Jul 20189:12 amRNSHolding(s) in Company
12th Jul 201811:47 amRNSDirector/PDMR Shareholding
9th Jul 20187:00 amRNSNotice of Results
12th Jun 20184:45 pmRNSDirector/PDMR Shareholding
4th Jun 20185:50 pmRNSDirector/PDMR Shareholding
4th Jun 20189:30 amRNSDirector Declaration
1st Jun 20184:39 pmRNSTotal Voting Rights
1st Jun 20184:37 pmRNSHolding(s) in Company
31st May 201811:57 amRNSDirector/PDMR Shareholding
29th May 20185:34 pmRNSDirector/PDMR Shareholding
22nd May 201812:28 pmRNSHolding(s) in Company
21st May 20184:04 pmRNSHolding(s) in Company
21st May 20187:00 amRNSDirector/PDMR Shareholding
17th May 20184:08 pmRNSHolding(s) in Company
16th May 20181:35 pmRNSResult of AGM
16th May 20187:00 amRNSCompletion of placing
15th May 20184:39 pmRNSProposed placing of shares in Zotefoams plc
14th May 20183:09 pmRNSDirector/PDMR Shareholding
13th Apr 20189:43 amRNSDirector/PDMR Shareholding
12th Apr 20182:27 pmRNS2017 Annual Report and Notice of the 2018 AGM
13th Mar 20185:30 pmRNSDirector/PDMR Shareholding
13th Mar 20187:00 amRNSFinal Results
9th Mar 20187:00 amRNSHolding(s) in Company
22nd Feb 20184:54 pmRNSHolding(s) in Company
22nd Feb 20184:48 pmRNSHolding(s) in Company
13th Feb 20187:00 amRNSDirector/PDMR Shareholding
16th Jan 20184:55 pmRNSHolding(s) in Company
12th Jan 201811:37 amRNSDirector/PDMR Shareholding
22nd Dec 201712:27 pmRNSDirector/PDMR Shareholding
21st Dec 20177:00 amRNSDirectorate Change
18th Dec 20174:10 pmRNSHolding(s) in Company
14th Dec 20177:00 amRNS£12 million investment planned at Croydon facility
13th Dec 20177:00 amRNSDirector/PDMR Shareholding
13th Dec 20177:00 amRNSStrategic Partnership with Nike
15th Nov 20177:00 amRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSThird Quarter Trading Update
17th Oct 20171:08 pmRNSDirector/PDMR Shareholding
10th Oct 20177:00 amRNSDirector/PDMR Shareholding
28th Sep 20177:00 amRNSHolding(s) in Company
13th Sep 20177:00 amRNSDirector/PDMR Shareholding
16th Aug 20177:00 amRNSHolding(s) in Company
11th Aug 20175:23 pmRNSHolding(s) in Company
10th Aug 20177:00 amRNSDirector/PDMR Shareholding
8th Aug 20177:00 amRNSDirectorate Changes
8th Aug 20177:00 amRNSHalf-year Report
20th Jul 20177:00 amRNSHolding(s) in Company
12th Jul 201710:19 amRNSDirector/PDMR Shareholding
3rd Jul 20174:35 pmRNSPrice Monitoring Extension
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
5th Jun 20172:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.